MedPath

Randomized comparative study for efficacy of esomeprazole and lansoprazole in the prevention of recurrent gastroduodenal ulcer in patients continuously treated with non-steroidal anti-inflammatory drugs

Not Applicable
Conditions
Gastroduodenal ulcer
Registration Number
JPRN-UMIN000016410
Lead Sponsor
ational Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with severe heart disease, acute cerebrovascular disease, hematological disease, severe liver disease, severe renal disease, or malignancy. 2) Pregnant women 3) Patients treated with Reyataz or Edulant 4) Patients with allergy for proton pump inhibitor 5) Patients with active gastroduodenal ulcers on the first time of this study 6) Patients with operative history of esophagus or stomach 7) Patients treated with steroids 8) Patients with alcoholism or drug dependence 9) Patients judged as unsuitable by investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
on-recurrent rate of gastroduodenal ulcer
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath